SCHOTT Pharma AG & Co. KGaA Working Capital to Net Assets Ratio
SCHOTT Pharma AG & Co. KGaA working capital to net assets ratio. SCHOTT Pharma AG & Co. KGaA (1SXP) has a Working Capital to Net Assets ratio of 19.3% as of September 2024. Working capital of €153.12 Million (current assets of €588.60 Million minus current liabilities of €435.48 Million) is measured against net assets of €792.27 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of SCHOTT Pharma AG & Co. KGaA (2020–2024)
Working capital to net assets ratio of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. This chart shows how SCHOTT Pharma AG & Co. KGaA's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2020 to 2024. As of September 2024, the ratio stands at 19.3%, reflecting working capital of €153.12 Million against net assets of €792.27 Million EUR. See SCHOTT Pharma AG & Co. KGaA defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
SCHOTT Pharma AG & Co. KGaA Working Capital to Net Assets Ratio by Year (2020–2024)
SCHOTT Pharma AG & Co. KGaA working capital to net assets ratio by year from 2020 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for SCHOTT Pharma AG & Co. KGaA from 2020 to 2024, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of SCHOTT Pharma AG & Co. KGaA.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 19.3% | €153.12 Million | €792.27 Million | €588.60 Million | €435.48 Million | ▲ +2.4 pp |
| 2023 | 16.9% | €117.19 Million | €692.18 Million | €468.34 Million | €351.15 Million | ▼ -15.7 pp |
| 2022 | 32.6% | €231.50 Million | €709.04 Million | €554.52 Million | €323.02 Million | ▲ +18.8 pp |
| 2021 | 13.8% | €57.95 Million | €419.42 Million | €302.16 Million | €244.21 Million | ▲ +4.6 pp |
| 2020 | 9.2% | €29.12 Million | €315.66 Million | €238.98 Million | €209.86 Million | — |